BIO-RAD LABORATORIES, INC. (BIO)
BIO-RAD LABORATORIES, INC. (BIO) from its SEC filings: 2025 revenue $2.6 billion (+1% vs the year before), net margin 29%, free cash flow $374.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Laboratory Analytical Instruments |
| Revenue (2025) | $2.6 billion |
| Revenue growth | +1% |
| Net income | $759.9 million |
| Net margin | 29.4% |
| Free cash flow | $374.6 million |
| Diluted EPS | $27.85 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -0% |
| Cash | $517.0 million |
| Long-term debt | $803.0 million |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.